Rhumbline Advisers trimmed its holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 25.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 53,569 shares of the business services provider's stock after selling 18,168 shares during the quarter. Rhumbline Advisers owned about 0.16% of Cross Country Healthcare worth $973,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Systematic Financial Management LP raised its stake in Cross Country Healthcare by 8.5% during the 3rd quarter. Systematic Financial Management LP now owns 1,662,730 shares of the business services provider's stock worth $22,347,000 after buying an additional 130,746 shares during the period. State Street Corp raised its stake in Cross Country Healthcare by 0.5% during the 3rd quarter. State Street Corp now owns 1,334,353 shares of the business services provider's stock worth $17,934,000 after buying an additional 6,582 shares during the period. Royce & Associates LP raised its stake in Cross Country Healthcare by 51.4% during the 3rd quarter. Royce & Associates LP now owns 1,132,566 shares of the business services provider's stock worth $15,222,000 after buying an additional 384,374 shares during the period. Jacobs Levy Equity Management Inc. acquired a new position in Cross Country Healthcare during the 3rd quarter worth approximately $7,350,000. Finally, Zweig DiMenna Associates LLC acquired a new position in Cross Country Healthcare during the 4th quarter worth approximately $6,841,000. 96.03% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on CCRN shares. William Blair downgraded Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 4th. Truist Financial increased their price objective on Cross Country Healthcare from $15.00 to $18.61 and gave the stock a "hold" rating in a research note on Thursday, December 5th. Barrington Research reissued a "market perform" rating on shares of Cross Country Healthcare in a research note on Tuesday, December 10th. StockNews.com started coverage on Cross Country Healthcare in a research note on Tuesday, March 4th. They issued a "hold" rating for the company. Finally, Benchmark downgraded Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 4th. Six investment analysts have rated the stock with a hold rating, According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $18.54.
Check Out Our Latest Stock Report on CCRN
Cross Country Healthcare Trading Up 0.8 %
Shares of CCRN stock traded up $0.13 during trading on Friday, hitting $15.93. The company's stock had a trading volume of 481,897 shares, compared to its average volume of 526,607. The company has a market cap of $522.76 million, a PE ratio of -318.54, a P/E/G ratio of 3.32 and a beta of 0.44. The business has a fifty day moving average of $17.92 and a 200-day moving average of $15.15. Cross Country Healthcare, Inc. has a 52 week low of $9.58 and a 52 week high of $19.25.
Cross Country Healthcare Profile
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.